| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/23/2003 | EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists |
| 04/23/2003 | EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303295A1 Agent for inhibiting adhesion of the pathogenic flora of the skin |
| 04/23/2003 | EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/23/2003 | EP1303284A1 Compositions and methods for the treatment of skin damage |
| 04/23/2003 | EP1303283A2 Treatment of hyperproliferative skin disorders and diseases |
| 04/23/2003 | EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 04/23/2003 | EP1303267A1 Dermal for amino laevulinic acid |
| 04/23/2003 | EP1303252A1 Composition comprising a ceramide precursor for improving natural or reconstructed epidermis, resulting skin equivalent |
| 04/23/2003 | EP1303251A1 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor |
| 04/23/2003 | EP1303249A1 Antimycotic nail varnish composition |
| 04/23/2003 | EP1303192A1 Dietary lipids for improving skin and coat of pets |
| 04/23/2003 | EP1220863B1 Purine derivatives |
| 04/23/2003 | EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/23/2003 | EP1185257A4 Treatment of acne using lipoic acid |
| 04/23/2003 | EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 04/23/2003 | EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 04/23/2003 | EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/23/2003 | EP0996409B1 Composition for delaying hair growth and corresponding use |
| 04/23/2003 | EP0889881B1 New triazoles as therapeutic agents for fungal infections |
| 04/23/2003 | EP0861266B1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 04/23/2003 | EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2003 | CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413206A Non peptide tachykinin receptor antagonists |
| 04/23/2003 | CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 04/23/2003 | CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels |
| 04/23/2003 | CN1413105A Novel method of treatment |
| 04/23/2003 | CN1411858A Medicine for curing scald and bed sore |
| 04/23/2003 | CN1411857A Tea oil ointment and suppository |
| 04/23/2003 | CN1411850A Hanxue Diwang tincture |
| 04/23/2003 | CN1411842A Chinese medicine capsule for curing facial acne |
| 04/23/2003 | CN1411836A Carthamus flower medicated liquor |
| 04/23/2003 | CN1411827A Capsule for curing acne |
| 04/23/2003 | CN1411826A Mark-removing capsule |
| 04/23/2003 | CN1411825A Medicine for curing burn and scald and its production method |
| 04/23/2003 | CN1411822A 疮疡愈合散 San sore healing |
| 04/23/2003 | CN1411817A Medicine for external application for curing psoriasis |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411807A Medicine for curing hoary hair and its preparation method |
| 04/23/2003 | CN1411802A Liquid preparation for external application for broad-spectrum sterilization and resisting herpes simplex virus |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/23/2003 | CN1106376C Cinnamylidene camphor derivatives and their use as UV-A optical protecting agents |
| 04/23/2003 | CN1106270C Multi-action particle for structuring biological media |
| 04/22/2003 | US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/22/2003 | US6552168 Inhibition of apoptosis via attenuation of caspase activity should therefore be useful in the treatment of human diseases where inappropriate apoptosis is prominent or contributes to disease pathogenesis |
| 04/22/2003 | US6552050 Method for enhancing protective cellular responses to genotoxic stress in skin |
| 04/22/2003 | US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
| 04/22/2003 | US6552040 Use of nitroxides in wound healing and in the prevention of photodamage |
| 04/22/2003 | US6552019 Inhibitors of p38 |
| 04/22/2003 | US6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF |
| 04/22/2003 | US6551996 Super-active porcine growth hormone releasing hormone analog |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551626 Composition containing pyrrolizidine-alkaloid-free petasites |
| 04/22/2003 | US6551625 Inhibiting disagreeable odors with extracts of undifferentiated plant cells |
| 04/22/2003 | US6551607 Method for sequestration of skin irritants with substrate compositions |
| 04/22/2003 | CA2068630C Use of protein c or activated protein c |
| 04/19/2003 | CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
| 04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
| 04/17/2003 | WO2003031434A1 Compounds and methods |
| 04/17/2003 | WO2003031430A2 Flavonoid compounds and their pharmaceutical uses |
| 04/17/2003 | WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
| 04/17/2003 | WO2003031400A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | WO2003030992A1 Betaine-containing cosmetics |
| 04/17/2003 | WO2003030944A2 Inhibition of stat-1 |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2003030930A1 Human 3 relaxin |
| 04/17/2003 | WO2003030919A1 Method of obtaining an extract of ginger |
| 04/17/2003 | WO2003030915A1 Use of solamargine for treating skin tumors |
| 04/17/2003 | WO2003030906A1 Treating infections by administration of oxazolidinones to the skin |
| 04/17/2003 | WO2003030905A1 Dihydroorotate dehydrogenase inhibitor |
| 04/17/2003 | WO2003030902A1 Imidazole derivates as anti-inflammatory agents |
| 04/17/2003 | WO2003030897A1 Pyrrolidinone derivatives |
| 04/17/2003 | WO2003030896A1 Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same |
| 04/17/2003 | WO2003030882A1 Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform |
| 04/17/2003 | WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | WO2003030857A1 Enhancing epidermal barrier development in skin |
| 04/17/2003 | WO2003030844A1 Long-acting hair growth stimulant preparations |
| 04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
| 04/17/2003 | WO2003030824A2 Methods and compositions for treating dermal lesions |
| 04/17/2003 | WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders |
| 04/17/2003 | WO2003030816A2 Combinatorial anti-acne compositions |
| 04/17/2003 | WO2003030814A2 Cross-regulin composition of turmeric-derived tetrahydrocurcuminoids for skin lightening and protection against uvb rays |
| 04/17/2003 | WO2003030813A2 Anti-irritating rosacea treatment |